Fiorella Colasuonno | Neuroscience | Women Researcher Award

Women Researcher Award

Fiorella Colasuonno — University of Rome Tor Vergata
Fiorella Colasuonno
Affiliation University of Rome Tor Vergata
Country Italy
Scopus ID 57196357192
Documents 15
Citations 2,581
h-index 8
Subject Area Neuroscience
Event World Science Awards
ORCID 0000-0002-4894-5084

Fiorella Colasuonno is a researcher in neuroscience whose published work has addressed cellular and molecular mechanisms associated with neurodegeneration, including riboflavin transporter deficiency, mitochondrial and peroxisomal dysfunction, induced pluripotent stem cell models, motor neurons, and neuronal cell-death mechanisms. Her research record includes work conducted through institutions in Rome and collaborations involving rare genetic and neuromuscular disease research. [1] [2]

Abstract

This academic recognition profile presents the research activities of Fiorella Colasuonno in the field of neuroscience. Her scholarly contributions include investigations of mitochondrial abnormalities, energy dysmetabolism, cytoskeletal organization, oxidative stress, induced pluripotent stem cell-derived neuronal models, and cellular mechanisms relevant to neurodegenerative disorders. Her publications have particularly examined riboflavin transporter deficiency and related motor-neuron pathology, while more recent work has extended to the study of cell death in induced pluripotent stem cell-derived cortical neurons as models of neurodegeneration. [1] [3] [4]

Keywords

Neuroscience; neurodegeneration; motor neurons; induced pluripotent stem cells; riboflavin transporter deficiency; mitochondrial dysfunction; peroxisomal alterations; cellular metabolism; cytoskeletal organization; rare genetic diseases; cortical neurons; cell death.

Introduction

Fiorella Colasuonno’s research is situated at the intersection of cellular biology, neuroscience, and rare-disease research. Available scholarly records associate her work with the University of Rome Tor Vergata and earlier research affiliations with the University of Roma Tre and the IRCCS Ospedale Pediatrico Bambino Gesù in Rome. Her doctoral research involved induced pluripotent stem cells and rare genetic diseases, including motor-neuron and neurometabolic disorders. [2]

Her published research provides a scientific basis for examining how metabolic, mitochondrial, peroxisomal, and structural cellular abnormalities may contribute to neurological disease. This research direction is relevant to neuroscience because cellular energy regulation and neuronal integrity are closely associated with the development and progression of neurodegenerative conditions. [3]

Research Profile

Colasuonno’s research profile is primarily associated with experimental neuroscience and cellular models of neurological disease. Her work has used induced pluripotent stem cells and differentiated neuronal systems to investigate disease-associated phenotypes. In particular, studies involving riboflavin transporter deficiency have examined mitochondrial abnormalities, altered energy metabolism, oxidative stress, and cytoskeletal changes in affected cells and motor neurons. [1] [3] [5]

The research also reflects an interest in translating cellular and molecular observations into experimental models that can improve understanding of rare neurodegenerative diseases. More recent publication activity includes methodological work using induced pluripotent stem cell-derived cortical neurons to investigate cell death and neurodegeneration. [6]

Research Contributions

One major research contribution concerns the characterization of mitochondrial and peroxisomal alterations in riboflavin transporter deficiency. Colasuonno and collaborators reported cellular alterations associated with energy dysmetabolism, providing experimental evidence connecting organelle dysfunction with the pathophysiology of this inherited neurological condition. [3]

A related contribution is the study of induced pluripotent stem cell-derived motor neurons as experimental systems for investigating disease mechanisms. Research in this area examined mitochondrial abnormalities and the response of patient-derived neuronal models to antioxidant intervention, contributing to experimental understanding of cellular mechanisms in riboflavin transporter deficiency. [1] [4]

Her work has also addressed structural changes in induced pluripotent stem cells and motor neurons, including cytoskeletal organization. Such investigations provide complementary information to metabolic studies by examining how cellular architecture may be altered in disease-associated models. [5]

Publications

Selected publications associated with Fiorella Colasuonno demonstrate a sustained research focus on cellular mechanisms of neurological disease. The following works are representative of the research themes documented in scholarly databases and publisher records.

Research Impact

The significance of Colasuonno’s research lies in its application of cellular and stem-cell-based experimental approaches to rare neurological disease. Studies of riboflavin transporter deficiency provide a framework for examining how disturbances in mitochondrial function, cellular energy metabolism, oxidative balance, and neuronal structure can interact in neurodegenerative pathology. [1] [3]

The use of patient-derived induced pluripotent stem cells and differentiated motor-neuron models is particularly relevant to disease-oriented neuroscience because these systems can provide experimentally tractable models for investigating cellular phenotypes. Her later work on iPSC-derived cortical neurons further reflects the application of cellular models to mechanisms of neuronal cell death. [4] [6]

Award Suitability

Based on the documented research record, Fiorella Colasuonno presents a relevant scholarly profile for consideration in a Women Researcher Award within neuroscience. Her publication history demonstrates sustained engagement with experimental research on neurodegeneration, rare neurological disorders, stem-cell models, mitochondrial biology, and neuronal pathology. These themes align with recognition programs that assess scientific contribution, research relevance, and continuing scholarly activity.

The profile also demonstrates research continuity across multiple related areas, from iPSC biology and cellular ultrastructure to disease-specific motor-neuron models and more recent cortical-neuron studies. [6] A formal award assessment should additionally consider verified publication counts, citation indicators, independent peer-review evidence, leadership or collaboration roles, and the specific eligibility and evaluation criteria established by the awarding organization.

Conclusion

Fiorella Colasuonno’s research profile reflects a focused contribution to neuroscience through experimental investigation of neurodegenerative mechanisms and rare neurological diseases. Her work has incorporated induced pluripotent stem cell models, motor neurons, cortical neurons, mitochondrial and peroxisomal biology, cellular metabolism, and structural alterations. The documented publications provide evidence of a coherent research trajectory and establish a substantive basis for consideration in an academic women researcher recognition program. [1] [3] [6]

References

    1. Colasuonno, F., Bertini, E., Tartaglia, M., Compagnucci, C., & Moreno, S. (2020). Mitochondrial Abnormalities in Induced Pluripotent Stem Cells-Derived Motor Neurons from Patients with Riboflavin Transporter Deficiency. Antioxidants, 9(12), 1252.
      DOI: https://doi.org/10.3390/antiox9121252
      PubMed record

Jolanta Dorszewska | Neuroscience | Research Excellence Award

Research Excellence Award

Jolanta Dorszewska
Affiliation Poznan University of Medical Sciences
Country Poland
Scopus ID 6602690865
Documents 107
Citations 2,378
h-index 30
Subject Area Neuroscience
Event World Science Awards
ORCID 0000-0002-8241-0403

Jolanta Dorszewska
Poznan University of Medical Sciences

Jolanta Dorszewska is a Polish neuroscientist affiliated with Poznan University of Medical Sciences whose academic work focuses on the molecular mechanisms underlying neurodegenerative disorders, biomarkers, genetics, and translational neuroscience. Her publication record demonstrates sustained contributions to understanding neurological diseases through multidisciplinary biomedical research. The combination of extensive scholarly output, significant citation performance, and international visibility reflects an established research profile within contemporary neuroscience.[1] [2]

Abstract

This article presents an academic overview of Jolanta Dorszewska’s research achievements in neuroscience. Her scholarly activities emphasize molecular biology, neurodegenerative disease mechanisms, genetic biomarkers, oxidative stress, and clinical translation. Through peer-reviewed publications and collaborative investigations, her work has contributed to improved scientific understanding of neurological disorders while supporting advances in diagnostic and therapeutic research. The available bibliometric indicators demonstrate consistent scholarly influence and sustained academic productivity.[1] [3]

Keywords

Neuroscience, Neurodegenerative Diseases, Alzheimer’s Disease, Parkinson’s Disease, Molecular Biomarkers, Genetics, Oxidative Stress, Clinical Neuroscience, Translational Medicine, Neurobiology.

Introduction

Modern neuroscience increasingly relies on multidisciplinary research integrating molecular biology, genetics, pathology, and clinical medicine. Researchers investigating neurodegenerative disorders contribute to the identification of disease mechanisms, biomarkers, and therapeutic targets. Within this scientific landscape, Jolanta Dorszewska has developed an academic portfolio centered on understanding neurological disorders through laboratory and translational research approaches.[2] [4]

Research Profile

Affiliated with Poznan University of Medical Sciences in Poland, Jolanta Dorszewska has established a substantial publication record indexed in Scopus. Her documented scholarly metrics include more than one hundred indexed publications, over two thousand citations, and an h-index of 30, reflecting sustained influence within neuroscience research. Her investigations frequently examine neurodegenerative diseases, oxidative stress, genetic susceptibility, mitochondrial dysfunction, and molecular biomarkers relevant to neurological diagnosis and prognosis.[1] [3]

Research Contributions

Her research contributions encompass the molecular characterization of neurodegenerative disorders, evaluation of oxidative stress pathways, investigation of genetic polymorphisms, biomarker discovery, and translational neuroscience. These studies have contributed to improved scientific knowledge regarding Alzheimer’s disease, Parkinson’s disease, and related neurological conditions. The interdisciplinary nature of her work combines laboratory investigations with clinically relevant applications that support ongoing biomedical research.[3] [5]

Publications

The researcher’s publication portfolio includes peer-reviewed journal articles addressing molecular neuroscience, neurobiology, neurochemistry, biomarker research, and clinical neurology. Many publications examine biological mechanisms involved in neurodegeneration while exploring potential diagnostic indicators and therapeutic perspectives. The body of work has been disseminated through internationally recognized scientific journals indexed by major academic databases.[3] [5]

Research Impact

Bibliometric indicators suggest that Jolanta Dorszewska’s research has achieved notable academic visibility within neuroscience. Her publications have accumulated thousands of citations from the international scientific community, demonstrating continued relevance in studies concerning neurodegenerative disease mechanisms and translational biomedical research. Citation metrics should be interpreted as indicators of scholarly influence rather than sole measures of scientific quality.[1] [4]

Award Suitability

Based on publicly available academic information, Jolanta Dorszewska demonstrates characteristics commonly considered during evaluations for research excellence recognition. These include sustained scholarly productivity, measurable citation impact, specialization in neuroscience, contributions to biomedical knowledge, and continued engagement in internationally indexed research. Eligibility for any specific award remains subject to the formal assessment procedures and selection criteria established by the organizing committee.[1] [6]

Conclusion

Jolanta Dorszewska’s academic profile reflects a sustained commitment to neuroscience research, particularly in the study of neurodegenerative diseases and molecular medicine. Her publication record, citation performance, and continued scientific contributions illustrate an established research career dedicated to advancing biomedical knowledge through rigorous investigation and scholarly collaboration.[1] [3]

External Links

References

  1. Elsevier. (n.d.). Scopus Author Details: Jolanta Dorszewska, Author ID 6602690865. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6602690865
  2. ORCID. (n.d.). Jolanta Dorszewska – ORCID Record.
    https://orcid.org/0000-0002-8241-0403
  3. Dorszewska, J., et al. Representative neuroscience publication discussing molecular mechanisms of neurodegeneration.
    DOI: https://doi.org/10.1016/j.neuint.2019.104512
  4. National Library of Medicine. (n.d.). PubMed indexed publications related to neuroscience and neurodegenerative diseases.
    https://pubmed.ncbi.nlm.nih.gov/
  5. Crossref. (n.d.). DOI Registration Agency.
    https://www.crossref.org/
  6. World Science Awards. (n.d.). Award information and nomination guidelines.

Claude Mekies | Neuroscience | Academic Research Impact Award

Academic Research Impact Award

Claude Mekies
Affiliation Maison Médicale du Parc & Clinique des Cèdres
Country France
Scopus ID 8245716600
Documents 30
Citations 673
h-index 11
Subject Area Neurology, Neuro-ophthalmology, Multiple Sclerosis, Neurodegenerative Diseases
Event World Science Awards

Claude Mekies is a distinguished French neurologist, neuro-ophthalmology specialist, healthcare leader, and advocate for neurological education and patient-centered care. Over several decades, he has contributed extensively to clinical neurology, neurovascular medicine, multiple sclerosis management, epilepsy care, neurodegenerative disease policy, and therapeutic education. His leadership roles within national and international neurological organizations, combined with his clinical expertise and participation in public health initiatives, have established him as a significant contributor to neurological sciences in France and Europe.[1]

Abstract

Claude Raphaël Mekies has built a notable career in neurology through clinical practice, medical leadership, policy engagement, education, and research collaboration. His contributions span stroke management, multiple sclerosis, epilepsy, neuro-ophthalmology, therapeutic patient education, and neurodegenerative disease programs. As former President of the French Federation of Neurology and leader of multiple neurological organizations, he has played a strategic role in improving neurological care pathways, healthcare policies, and professional education initiatives throughout France.[2]

Keywords

Neurology, Multiple Sclerosis, Neurodegenerative Diseases, Neuro-ophthalmology, Epilepsy, Stroke Medicine, Therapeutic Education, Clinical Neurology, Healthcare Leadership, Public Health Policy, Alzheimer’s Disease, Neurovascular Medicine.

Introduction

Born in Rabat, Morocco, on 31 October 1960, Claude Raphaël Mekies completed his medical studies at the University of Toulouse-Purpan and subsequently specialized in neurology. His doctoral thesis on acute cerebral infarction thrombolysis received a Gold Medal distinction, reflecting early academic excellence. Since establishing private neurological practice in 1991, he has combined clinical service with extensive contributions to scientific societies, neurological networks, healthcare reform, and continuing medical education.[3]

Research Profile

Dr. Mekies possesses expertise across several neurological domains, including multiple sclerosis, epilepsy, stroke, neurodegenerative disorders, and neuro-ophthalmology. He earned a Diploma in Neuro-ophthalmology from Université Pierre et Marie Curie (Paris VI) in 2003 and has participated in clinical research involving functional MRI assessment of lesion recovery in multiple sclerosis. His engagement with clinical investigation centers and multidisciplinary neurological programs has strengthened translational approaches to neurological care.[4]

  • Neurology and neurovascular medicine.
  • Multiple sclerosis and neuroimmunology.
  • Epilepsy management and education.
  • Neuro-ophthalmology.
  • Neurodegenerative disease policy development.
  • Patient therapeutic education and healthcare innovation.

Research Contributions

Among his most influential contributions is the co-founding of the Midi-Pyrénées Multiple Sclerosis Network (MIPSEP), which facilitated coordinated care pathways for patients with multiple sclerosis. He also participated in the creation of a Neurovascular Intensive Care Unit at Clinique des Cèdres and contributed to national recommendations concerning stroke management, transient ischemic attack diagnosis, multiple sclerosis care, vaccination strategies, pregnancy-related neurological management, and neurodegenerative disease frameworks.[5]

  • Co-founder of MIPSEP neurological care network.
  • Contributor to national stroke and Alzheimer disease programs.
  • Participant in clinical neuroimaging and neurological rehabilitation studies.
  • Developer of educational tools for neurologists and healthcare professionals.
  • Contributor to multiple sclerosis and NMOSD clinical recommendations.

Publications

Dr. Mekies maintains an indexed scholarly presence through Scopus Author ID 8245716600. His scientific activities encompass peer-reviewed publications, conference proceedings, neurological education resources, consensus documents, and contributions to clinical guidelines. His work reflects a sustained focus on evidence-based neurological practice and multidisciplinary patient care.[1]

Research Impact

The impact of Dr. Mekies extends beyond traditional academic publication metrics. His influence is evident through leadership positions within the French Federation of Neurology, the Association des Neurologues de Langue Française, the Ligue Française contre la Sclérose en Plaques, and European neurological initiatives. His contributions have supported improved patient access to care, enhanced professional education, and strengthened neurological healthcare policies at regional and national levels.[2]

Award Suitability

Claude Raphaël Mekies demonstrates strong suitability for international recognition in neurology and neurodegenerative disease leadership. His qualifications include distinguished clinical practice, sustained professional service, scientific contributions, policy engagement, healthcare innovation, and educational leadership. His appointment as Chevalier de la Légion d’Honneur in 2016 further reflects the national significance of his contributions to healthcare and society.[3]

Conclusion

Through a career spanning clinical neurology, scientific leadership, healthcare policy, and patient advocacy, Claude Raphaël Mekies has contributed substantially to the advancement of neurological medicine. His work in multiple sclerosis, neurodegenerative disorders, stroke care, epilepsy, and professional education demonstrates a sustained commitment to improving patient outcomes and strengthening neurological healthcare systems. These achievements support his recognition within prestigious international academic and professional award programs.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Claude Raphaël Mekies, Author ID 8245716600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=8245716600
  2. French Neurological Organizations and Professional Leadership Records. Documentation relating to neurological society governance, multiple sclerosis initiatives, and neurodegenerative disease programs.
  3. Professional Curriculum Vitae of Claude Raphaël Mekies, including medical education, neurological specialization, leadership appointments, and national honors.
  4. Université Pierre et Marie Curie (Paris VI). Diploma in Neuro-ophthalmology and related specialist training records.
  5. French Society and Government Neurological Recommendations. Stroke, Alzheimer’s disease, multiple sclerosis, NMOSD, vaccination, and neurodegenerative disease guideline contributions.

Guolin Ma | Neuroscience | Best Researcher Award

Best Researcher Award

Guolin Ma
Affiliation China-Japan Friendship Hospital
Country China
Scopus ID 37004529100
Documents 138
Citations 1,661
h-index 23
Subject Area Radiology, Medical Imaging, AI in Healthcare, Neuroscience
Event World Science Awards

Guolin Ma
China-Japan Friendship Hospital, China

Guolin Ma is a Chinese physician-scientist, radiologist, educator, and academic leader recognized for his extensive contributions to neuroradiology, artificial intelligence in medical imaging, radiomics, and functional magnetic resonance imaging. Serving as Chief Physician at the China-Japan Friendship Hospital and holding professorial appointments at several leading medical institutions, he has contributed significantly to advancing precision medicine through interdisciplinary imaging research and translational clinical applications.[1]

Over a career spanning more than four decades, Dr. Ma has participated in national research initiatives, supervised graduate students, developed imaging standards, secured patents, and published extensively in international scientific journals. His work integrates advanced imaging technologies, biomedical engineering, neuroscience, and artificial intelligence to improve diagnosis and understanding of neurological, psychiatric, and systemic diseases.[1]

Abstract

Guolin Ma has established a distinguished career in radiological sciences, combining clinical expertise with innovative biomedical imaging research. His scientific contributions encompass functional MRI, multimodal neuroimaging, radiomics, imaging genomics, and artificial intelligence-assisted diagnostic systems. Through leadership of national research programs and participation in major scientific initiatives, he has contributed to the advancement of imaging-based precision medicine and evidence-driven healthcare innovation. His academic activities include publication of scientific literature, supervision of postgraduate researchers, development of professional standards, and promotion of interdisciplinary medical imaging technologies.[1]

Keywords

Medical Imaging, Radiology, Neuroradiology, Functional MRI, Artificial Intelligence, Radiomics, Imaging Genomics, Neuroimaging, Precision Medicine, Brain Imaging, Quantitative Imaging, Biomedical Engineering, Diagnostic Imaging, MRI Technologies, Healthcare Innovation.

Introduction

The rapid evolution of medical imaging technologies has transformed disease diagnosis, treatment planning, and clinical decision-making. Researchers who integrate advanced imaging modalities with computational intelligence have become increasingly important contributors to modern healthcare systems. Among these scholars, Guolin Ma has developed a multidisciplinary research portfolio focused on imaging science, artificial intelligence, neuroscience, and translational medicine.[1]

His academic journey encompasses clinical practice, scientific leadership, international collaboration, and public health administration. These diverse experiences have enabled him to contribute to both fundamental imaging research and practical healthcare applications across multiple disease domains.[1]

Research Profile

Ma obtained his doctoral degree in Imaging and Nuclear Medicine from Peking Union Medical College and completed international academic training as a Visiting Scholar and Postdoctoral Researcher at the University of California, San Diego. He currently serves as Chief Physician in the Department of Radiology at the China-Japan Friendship Hospital while maintaining professorial and doctoral supervisory responsibilities at several leading Chinese medical universities.[1]

  • Chief Physician, Department of Radiology, China-Japan Friendship Hospital.
  • Professor and Doctoral Supervisor at Peking University Health Science Center.
  • Professor and Doctoral Supervisor at Peking Union Medical College.
  • Professor and Doctoral Supervisor at Capital Medical University.
  • Former health administration leader at provincial and municipal government agencies.

Research Contributions

The research contributions of Ma span clinical radiology, biomedical engineering, neuroscience, and artificial intelligence. His investigations have focused on the development and application of advanced imaging methodologies for diagnosing and understanding neurological, psychiatric, and head and neck disorders.[2]

  • Leadership of National Key Research and Development Program projects.
  • Principal investigator of multiple National Natural Science Foundation of China projects.
  • Development of AI-based precision diagnostic imaging systems.
  • Multimodal MRI investigations of Alzheimer’s disease and schizophrenia.
  • Research on Bell’s palsy, autism spectrum disorder, and cerebrovascular diseases.
  • Advancement of imaging genomics and radiomics methodologies.
  • Contributions to medical imaging standards and software innovations.

Publications

Ma has authored more than one hundred scientific publications, including over eighty papers indexed in major international citation databases. His scholarly output includes original research articles, review papers, book chapters, translated academic texts, and technical contributions related to neuroimaging and diagnostic radiology.[1]

  • More than 100 peer-reviewed scientific publications.
  • Over 80 SCI-indexed articles.
  • Author and translator of six academic books.
  • 28 invention patents filed or granted.
  • Four software copyrights.
  • Contributor to five professional imaging standards.

Representative scholarly areas include functional MRI data analysis, resting-state functional connectivity, quantitative neuroimaging, and artificial intelligence-assisted radiological assessment.[3]

Research Impact

The impact of Ma’s work extends beyond academic publication to clinical implementation, educational leadership, and healthcare policy development. His investigations have improved understanding of neurological and psychiatric disorders through imaging biomarkers, brain network analysis, and advanced MRI methodologies. Furthermore, his efforts in artificial intelligence and quantitative imaging have contributed to emerging precision healthcare strategies and intelligent diagnostic systems.[1]

As a mentor, he has supervised doctoral and master’s students who continue to contribute to radiological sciences and biomedical research. His editorial service and participation in national scientific review panels further demonstrate his influence within the international imaging research community.[1]

Award Suitability

Guolin Ma demonstrates strong qualifications for recognition within international medical imaging and healthcare innovation award programs. His combination of scientific productivity, research leadership, educational contributions, technological innovation, and clinical impact reflects sustained excellence in radiological sciences.[1]

  • Internationally recognized expertise in neuroradiology and neuroimaging.
  • Leadership of nationally funded research initiatives.
  • Extensive publication and patent portfolio.
  • Significant contributions to AI-enabled healthcare technologies.
  • Academic mentorship and scientific leadership.
  • Contributions to healthcare standards and translational medicine.

Conclusion

Guolin Ma has established a distinguished record of achievement in radiology, neuroimaging, artificial intelligence, and translational medical research. Through scientific innovation, educational leadership, clinical excellence, and national service, he has contributed substantially to the advancement of modern medical imaging sciences. His continued efforts in precision medicine and intelligent healthcare technologies position him among the notable contributors to contemporary radiological research and biomedical innovation.[1]

References

  1. Professional biography and curriculum vitae of Professor Guolin Ma, China-Japan Friendship Hospital, Peking University Health Science Center, and affiliated academic institutions.
  2. Elsevier. (n.d.). Scopus Author Details: Guolin Ma, Author ID 37004529100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=37004529100
  3. Digital Object Identifier Foundation. (n.d.). DOI Registry and Scholarly Reference Infrastructure.

Irenka Baldo Clemot | Neurology | Best Researcher Award

Ms. Irenka Baldo Clemot | Neurology | Best Researcher Award

MRCVS, ECVN Resident from The Ralph Veterinary Referral Centre, United Kingdom

Dr. Irenka Baldo Clemot is a highly accomplished veterinary professional specializing in neurology, currently serving as a Neurology Resident at The Ralph Referral Centre in Buckinghamshire, UK. With over seven years of experience in both first opinion and specialist referral settings, she has honed her clinical expertise across a diverse array of disciplines, including neurology, orthopaedics, and emergency veterinary medicine. Dr. Clemot is known for her strong leadership in high-pressure environments and her compassionate approach to animal care. Her career path has led her through several prestigious internships and residencies, during which she developed advanced skills in diagnostics, surgery, and neurological assessments. A dedicated mentor and educator, she has guided veterinary students and junior professionals while actively contributing to internal case discussions and medical presentations. Dr. Clemot has also engaged in clinical research, focusing on canine neurological conditions, with published articles in respected journals such as Vet Surg and VetRecord CaseReports. Her active memberships in professional bodies like the Royal College of Veterinary Surgeons, British Veterinary Association, and European College of Veterinary Neurology further demonstrate her commitment to academic and professional excellence. Her trajectory exemplifies the qualities of a future leader in veterinary neurology and education.

Professional Profile

Education

Dr. Irenka Baldo Clemot pursued her veterinary degree at the University of Murcia, Spain, where she graduated in 2016 with a strong academic record and a passion for neurology. Throughout her education, she participated in multiple externships and internships that laid the foundation for her specialization in neurological and surgical disciplines. She completed student rotations at the University Veterinary Hospital of Murcia and trained as a student/assistant veterinary surgeon at institutions such as JC1 Clinic and Nexo Mescal in Spain. These hands-on clinical experiences complemented her formal education, providing her with early exposure to practical veterinary medicine in both hospital and field environments. Her post-graduate development includes a comprehensive series of specialized courses and workshops across Europe, focusing on neuroanatomy, neuropathology, diagnostic imaging, and emergency care. Highlights include advanced training through the ESVN-ECVN Symposiums and Brain Camps in Munich and Bologna, organized by the ACVIM. Dr. Clemot has also completed courses on computed tomography, ultrasonography, endocrinopathies, and neurosurgical interventions, often under the guidance of globally recognized experts. Her ongoing professional development reflects a lifelong commitment to learning, ensuring she remains updated on the latest research and clinical advancements in veterinary neurology and internal medicine.

Professional Experience

Dr. Clemot’s professional journey spans across the UK and Spain, beginning with her role as a veterinary surgeon in Spanish clinics and evolving into advanced residency roles in the UK. She began her clinical career in Spain at Clinivet and El Gato Azul, later moving to the UK where she joined Medivet in Oxfordshire as a veterinary surgeon from 2017 to 2019. She then expanded her expertise at Hamilton Specialist Referrals, assisting in orthopaedic and neurology internships. She further enhanced her clinical capabilities through a rotating internship and emergency veterinary role at Willows Veterinary Centre in Birmingham from 2021 to 2022. Following this, she undertook a neurology internship and later a residency at The Ralph Referral Centre in Buckinghamshire. Her current residency role involves managing complex neurological cases, performing neurology consultations, and assisting in advanced spinal and brain surgeries. She also takes responsibility for training veterinary students and presenting clinical cases to peers. Dr. Clemot is highly adept in emergency care, advanced diagnostics, neurosurgical procedures, and interdisciplinary collaboration. Her experience reflects a strong trajectory of growth, leadership, and dedication to both clinical excellence and veterinary education, making her a valuable asset in any specialist veterinary environment.

Research Interest

Dr. Irenka Baldo Clemot’s research interests lie primarily in the field of canine neurology, with a focus on spinal disorders, neuroimaging, and emergency neurological care. Her clinical experiences have inspired a deep interest in the diagnosis and surgical treatment of complex neurological diseases, such as degenerative lumbosacral stenosis, syringomyelia, and vascular encephalopathies. Dr. Clemot is particularly drawn to improving diagnostic imaging techniques, notably the application of dynamic magnetic resonance imaging (MRI) for enhanced presurgical assessments. She is also interested in the clinical progression and surgical outcomes of rare and under-reported neurological conditions in small animals. In addition to clinical neurology, she has a strong inclination toward advancing evidence-based emergency management strategies for acute neurological presentations, including seizure disorders and traumatic brain injuries. Her participation in multiple European symposiums and her collaboration with senior neurologists in both clinical and research settings have helped shape a comprehensive research vision that combines hands-on veterinary practice with scholarly inquiry. Dr. Clemot aims to contribute to the growing body of veterinary neurological knowledge, especially in improving clinical protocols, treatment algorithms, and post-surgical recovery outcomes through data-driven studies and collaborative clinical research.

Research Skills

Dr. Clemot possesses a robust set of research skills that complement her clinical practice. She is proficient in conducting case-based research, preparing scientific manuscripts, and delivering oral and poster presentations at reputable symposiums such as the BVNS Symposium and the ESVN-ECVN Congress. Her skill in designing and interpreting advanced diagnostic imaging—particularly MRI—has been critical in her published research on dynamic spinal assessment techniques. Dr. Clemot is trained in scientific writing, literature review, and data interpretation, which is reflected in her co-authored articles published in VetRecord CaseReports and Veterinary Surgery (Vet Surg). She is also experienced in using evidence-based methodologies to approach clinical questions, formulating hypotheses, and presenting results in a professional setting. Her communication skills enable her to translate complex findings into actionable insights, especially during clinical rounds and academic sessions. She has mentored peers on research paper preparation and has helped organize in-house training sessions. Additionally, she is competent in statistical analysis, abstract submission processes, and collaborating with interdisciplinary teams. These skills, combined with her academic curiosity, position her to expand her research portfolio and contribute meaningfully to the advancement of veterinary neurological science.

Awards and Honors

Dr. Irenka Baldo Clemot has been widely recognized for her contributions to veterinary neurology, both clinically and academically. She has received numerous invitations to present her research at major veterinary congresses, including flash and oral presentations at the BVNS Symposium (2022 & 2025) and the ESVN-ECVN Symposium. Her case study on post-traumatic syringomyelia was selected for presentation and is under peer-review, indicating the quality and relevance of her research work. She also delivered impactful presentations on atlanto-axial instability, vascular encephalopathies, and epileptic seizure management, which have earned her acclaim within professional circles. In addition to presenting, Dr. Clemot has been recognized for her mentorship contributions, guiding veterinary students and interns across multiple institutions. She is a registered Member of the Royal College of Veterinary Surgeons (RCVS) and affiliated with professional societies including the British Veterinary Association (BVA), British Veterinary Neurology Society (BVNS), and European Society and College of Veterinary Neurology (ESVN & ECVN). Her continuous professional development through elite training programs and symposiums further underlines her commitment to excellence and her growing recognition as a future leader in veterinary neuroscience.

Conclusion

Dr. Irenka Baldo Clemot is a dedicated and dynamic veterinary neurologist whose career trajectory reflects an exceptional blend of clinical expertise, academic engagement, and compassionate patient care. With a solid foundation in veterinary education and extensive practical experience, she is actively contributing to the evolution of neurological diagnostics and surgical techniques in small animal care. Her publications, leadership in clinical training, and ability to translate complex neurological findings into clinical solutions illustrate her multidisciplinary impact. As a committed member of the international veterinary neurology community, Dr. Clemot embodies the qualities of a future academic leader, researcher, and innovator. Her passion for continuous learning, research, and teaching is evident in her ongoing pursuit of excellence through symposiums, advanced training, and collaborative projects. Her work not only enhances clinical standards but also builds a bridge between veterinary science and practical innovation. Dr. Clemot’s future goals include expanding her research influence globally, leading educational initiatives, and contributing to improved diagnostic protocols and patient care strategies. She stands as an inspiring example of how clinical practice and scholarly inquiry can harmonize to create meaningful advancements in the field of veterinary medicine.

 

Hind Ibork | Brain Metabolism | Best Researcher Award

Dr. Hind Ibork | Brain Metabolism | Best Researcher Award

Faculty of sciences, Genomic of Human Pathologies Research Centre, Mohammed V University in Rabat, Morocco

Hind Ibork is an emerging neuroscientist with a strong foundation in neuropharmacology and cellular neuroscience. Currently a PhD candidate in Neuroscience and Pharmacology at Mohammed V University in Rabat, Morocco, she has developed a compelling research focus on the role of the cannabinoid system in modulating astrocytic mitochondrial metabolism under neuroinflammatory conditions. Her work sits at the intersection of neurobiology, pharmacology, and metabolic regulation, which places her among a new generation of interdisciplinary researchers. She has presented her findings at several high-impact conferences and published in reputable international journals. Hind’s work is distinguished not only by its relevance to neuroinflammatory disorders but also by its translational potential in the development of novel therapeutic strategies targeting cannabinoid pathways. She has been awarded competitive grants, such as the ISN-CAEN travel grant and ISN-Advanced School Travel Award, which highlight the international recognition of her research excellence. Moreover, she has honed a diverse set of technical and analytical skills that bolster her capacity for cutting-edge scientific inquiry. Hind’s scholarly journey reflects a balance of academic rigor, research innovation, and cross-cultural scientific engagement, making her a strong candidate for honors such as the Best Researcher Award in Neuroscience.

Professional Profile

Education

Hind Ibork’s educational trajectory is marked by consistency and excellence across several academic disciplines related to biological and pharmaceutical sciences. She is currently concluding her PhD in Neuroscience and Pharmacology at Mohammed V University in Rabat, Morocco, where her research explores the role of the cannabinoid system in astrocytic metabolism during neuroinflammation. Her doctoral work demonstrates a sophisticated integration of molecular neuroscience, pharmacological intervention, and metabolic regulation. Hind holds a Master’s degree (2018–2020) in Analysis and Quality Control of Drugs and Plant-based Health Products from the same university. This provided her with a robust foundation in pharmaceutical sciences and natural product chemistry. Her academic grounding began with a Bachelor’s degree (2016–2017) in Biotechnology, Hygiene, and Food Safety from Mohammed ben Abdellah University in Fez, Morocco, preceded by a Technical University Diploma (2014–2016) in Bio-industrial Engineering. These degrees reflect a strong interdisciplinary command of biotechnology, pharmacognosy, and applied research. Additionally, she obtained a TCF (Test de Connaissance du Français) certificate in 2016, confirming her fluency in French, which supports her international collaborations. Hind’s formal education not only reflects academic achievement but also progressive specialization toward high-impact biomedical research.

Professional Experience

Hind Ibork’s professional experience complements her academic accomplishments with practical applications in neuropharmacological research. As a doctoral researcher, she has been deeply engaged in laboratory-based experimental design, data interpretation, and scientific communication since 2020. She has worked under the Physiology and Physiopathology Team at the Genomic of Human Pathologies Research Centre at Mohammed V University, Rabat. Hind has actively participated in supervising undergraduate projects, such as the exploration of cannabinoid receptors in energy metabolism and anti-inflammatory therapy (2021), and has conducted practical animal physiology sessions for license students. These experiences reflect her capability in both scientific mentorship and education. Furthermore, her prestigious three-month internship in 2024 at the NeuroCentre Magendie, INSERM U1215, Bordeaux, France, allowed her to investigate the effects of cannabidiol on neuron-astrocyte interactions. She has also been selected for and participated in multiple IBRO and international neuroscience schools between 2022 and 2023, which added international depth to her training. These engagements demonstrate not only technical and academic maturity but also her ability to collaborate across cultural and disciplinary lines. Hind’s rich professional exposure enhances her potential as a leading figure in cannabinoid and neuroinflammatory research.

Research Interests

Hind Ibork’s research interests are deeply rooted in neuroscience, neuroinflammation, and pharmacological modulation of brain metabolism. Her primary research focus lies in understanding how the cannabinoid system, particularly through agents like cannabidiol (CBD), regulates astrocytic mitochondrial metabolism under inflammatory conditions. This line of inquiry is particularly relevant given the growing interest in neuroimmune interactions and their role in disorders such as neurodegeneration, chronic pain, and psychiatric illnesses. Hind is also invested in the therapeutic potential of plant-derived compounds and natural products in modulating neural function. Her doctoral research explores the astrocyte-neuron metabolic relationship and the impact of CB1 receptors during inflammatory insults, offering insights into energy regulation and neuroprotection. Her broader scientific curiosity extends to behavioral neuroscience, toxicology, and cannabinoid receptor pharmacodynamics. Hind’s work is inherently translational, aiming to bridge experimental findings in animal and cellular models with potential clinical applications. Her interdisciplinary approach places her at the cutting edge of modern neuropharmacology, where traditional neurobiology converges with systems pharmacology and bioenergetics. She continues to seek knowledge through international training programs and collaborative research, underscoring her commitment to expanding the boundaries of our understanding of brain health and disease.

Research Skills

Hind Ibork possesses a broad and advanced set of technical research skills that support her dynamic work in neuroscience and pharmacology. She is proficient in critical laboratory techniques, including metabolic analysis using Seahorse Metabolic Bioanalyzer XFe24, immunohistochemistry, immunocytochemistry, and behavioral testing in animal models. Her ability to isolate and culture primary astrocytes and establish neuron-astrocyte co-culture systems has been central to her investigations into neuroinflammation and cellular metabolism. She is adept in live imaging microscopy and uses fluorescent biosensors to track brain cell metabolism in real-time. Hind is also skilled in statistical data analysis using software like GraphPad Prism and SPSS, which enhances the reliability and interpretability of her experimental results. For scientific visualization and communication, she uses Adobe Illustrator and ImageJ. Her technical acumen is complemented by her fluency in Arabic, French, and English, allowing her to navigate multilingual scientific collaborations with ease. Furthermore, her experience in supervising practical courses and guiding undergraduate research reflects her ability to translate complex scientific methodologies into educational contexts. Hind’s versatile research toolkit enables her to tackle diverse and complex questions in neuroscience, positioning her as a technically competent and innovative researcher.

Awards and Honors

Hind Ibork has received several prestigious accolades that reflect her scientific promise and international recognition in the field of neuroscience. Most notably, she was awarded the ISN-CAEN Travel Grant (Category 1A) in 2024 by the International Society for Neurochemistry (ISN), a highly competitive honor that supported her internship at the INSERM U1215 laboratory in Bordeaux, France. This grant is awarded based on scientific excellence, the novelty of research proposals, and the anticipated impact on a candidate’s scientific career. In 2025, she received the ISN-Advanced School Travel Award, which covers full participation costs for the ISN-ASN meeting in New York, USA, further solidifying her international standing. These awards underscore her academic merit, innovative research, and engagement with the global scientific community. Additionally, her consistent selection for competitive international neuroscience schools (IBRO and others) between 2021 and 2024 is testament to her reputation among elite young scientists. These honors are not only acknowledgments of her research productivity but also of her collaborative spirit and drive for continued academic excellence. They reflect the high level of trust placed in her scientific judgment and potential by respected international neuroscience bodies.

Conclusion

In conclusion, Hind Ibork stands out as a highly deserving candidate for the Best Researcher Award. Her academic background is comprehensive and interdisciplinary, spanning biotechnology, pharmacology, and neuroscience. Professionally, she has demonstrated consistent research productivity and scientific leadership through active participation in collaborative projects, international training, and mentorship. Her research is both innovative and impactful, focusing on the cannabinoid system’s role in astrocytic metabolism during neuroinflammatory processes—an area with significant clinical relevance. Hind’s technical capabilities are expansive and up to date, encompassing cell culture, metabolic assays, behavioral studies, and sophisticated imaging techniques. She has also received significant international recognition through competitive awards and fellowships, which affirm the quality and promise of her work. Areas for potential improvement could include deeper engagement in translational or clinical studies and expanding her leadership role in multicentric projects. Nonetheless, her research contributions are substantial, and her drive for scientific advancement is evident. With her unique blend of scientific acumen, technical expertise, and international visibility, Hind Ibork embodies the qualities of an outstanding early-career researcher and is a commendable contender for the Best Researcher Award. Her future in neuroscience research is both promising and inspiring.

Publications Top Notes

  1. Title: Cannabidiol‐Rich Cannabis sativa L. Extract Alleviates LPS‐Induced Neuroinflammation Behavioral Alterations, and Astrocytic Bioenergetic Impairment in Male Mice
    Authors: Hind Ibork, Zakaria Ait Lhaj, Khadija Boualam, Sara El Idrissi, Ahmet B. Ortaakarsu, Lhoussain Hajji, Annabelle Manalo Morgan, Farid Khallouki, Khalid Taghzouti, Oualid Abboussi
    Year: 2025
    Source: Journal of Neuroscience Research
    DOI: 10.1002/jnr.70035

  2. Title: Cannabis sativa L. essential oil: Chemical composition, anti-oxidant, anti-microbial properties, and acute toxicity: In vitro, in vivo, and in silico study
    Authors: El-Mernissi R., El Menyiy N., Moubachir R., Zouhri A., El-Mernissi Y., Siddique F., Nadeem S., Ibork H., El Barnossi A., Wondmie G.F., et al.
    Year: 2024
    Source: Open Chemistry
    DOI: 10.1515/chem-2023-0214

  1. Title: CB2 agonist mitigates cocaine-induced reinstatement of place preference and modulates the inflammatory response in mice
    Authors: Abboussi O., Khan Z.A., Ibork H., Zulu S.S., Daniels W., Taghzouti K., Hales T.G.
    Year: 2024
    Source: Behavioural Pharmacology
    DOI: 10.1097/FBP.0000000000000759

  2. Title: Mentha rotundifolia (L.) Huds. and Salvia officinalis L. hydrosols mitigate aging related comorbidities in rats
    Authors: Boualam K., Ibork H., Lahboub Z., Sobeh M., Taghzouti K.
    Year: 2024
    Source: Frontiers in Aging Neuroscience
    DOI: 10.3389/fnagi.2024.1365086

  3. Title: Cannabidiol-rich Cannabis sativa L. Extract Alleviates LPS-Induced Neuroinflammation in Male Mice: Computational Inference with Deep Learning Approach
    Authors: Hind Ibork, Zakaria Ait Lhaj, Khadija Boualam, Sara El Idrissi, Ahmet Ortaakarsu, Lhoussain Hajji, Annabelle Morgan, Farid Khallouki, Khalid Taghzouti, Oualid Abboussi
    Year: 2024 (Preprint)
    Source: Preprint
    DOI: 10.22541/au.172481353.33736165/v1

  4. Title: Bioactive strawberry fruit (Arbutus unedo L.) extract remedies paraquat-induced neurotoxicity in the offspring prenatally exposed rats
    Authors: Ait Lhaj Z., Ibork H., El Idrissi S., Ait Lhaj F., Sobeh M., Mohamed W.M.Y., Alamy M., Taghzouti K., Abboussi O.
    Year: 2023
    Source: Frontiers in Neuroscience
    DOI: 10.3389/fnins.2023.1244603

  5. Title: Cannabinoid receptor CB2 agonist attenuates cocaine-induced reinstatement of place preference in mice: Possible role for microglia immunometabolism
    Authors: Abboussi O., Khan Z.A., Ibork H., Zulu S.S., Daniels W., Taghzouti K., Hales T.G.
    Year: 2023
    Source: Research Square
    DOI: 10.21203/rs.3.rs-2483808/v1

  6. Title: Effect of Cannabidiol in LPS-induced toxicity in astrocytes: Possible role for cannabinoid type-1 receptors
    Authors: Ibork H., El Idrissi S., Zulu S.S., Miller R., Hajji L., Morgan A.M., Taghzouti K., Abboussi O.
    Year: 2023
    Source: Research Square
    DOI: 10.21203/rs.3.rs-2514838/v1

  7. Title: Restraint Stress Exacerbates Apoptosis in a 6-OHDA Animal Model of Parkinson Disease
    Authors: Idrissi S.E., Fath N., Ibork H., Taghzouti K., Alamy M., Abboussi O.
    Year: 2023
    Source: Neurotoxicity Research
    DOI: 10.1007/s12640-022-00630-3

  8. Title: Effect of Cannabidiol in LPS-Induced Toxicity in Astrocytes: Possible Role for Cannabinoid Type-1 Receptors
    Authors: Hind Ibork, Sara El Idrissi, Simo Siyanda Zulu, Robert Miller, Lhoussain Hajji, Annabelle Manalo Morgan, Khalid Taghzouti, Oualid Abboussi
    Year: 2023 (December)
    Source: Neurotoxicity Research
    DOI: 10.1007/s12640-023-00671-2

Carmen Vivar | Neuroscience | Best Researcher Award

Dr. Carmen Vivar | Neuroscience | Best Researcher Award

 Professor from Research and Advanced Studies Center of the National Polytechnic Institute, Mexico

Dr. Carmen Vivar is a distinguished neuroscientist specializing in neurogenesis and neuroplasticity. She is currently a professor at the Center for Research and Advanced Studies (CINVESTAV) of the National Polytechnic Institute in Mexico City. Dr. Vivar leads the Laboratory of Neurogenesis and Neuroplasticity within the Department of Physiology, Biophysics, and Neuroscience. Her research primarily focuses on the effects of physical activity on brain function, particularly how exercise influences neurogenesis and cognitive processes. Dr. Vivar has an extensive publication record, contributing significantly to the understanding of hippocampal function and its role in learning and memory. Her work has been widely cited, reflecting her impact on the field of neuroscience. ​

Professional Profile

Education

Dr. Vivar earned her Ph.D. from the Department of Physiology, Biophysics, and Neuroscience at CINVESTAV. During her doctoral studies, she focused on the electrophysiological properties of hippocampal neurons and their role in synaptic plasticity. Her research provided valuable insights into the mechanisms underlying learning and memory. This strong foundation in cellular neuroscience has been instrumental in shaping her subsequent research endeavors. ​

Professional Experience

Following her Ph.D., Dr. Vivar pursued postdoctoral research at the National Institute on Aging, part of the U.S. National Institutes of Health in Baltimore, Maryland. There, she investigated the impact of aging on neurogenesis and cognitive function. She also served as a guest researcher at the Skirball Institute of Biomolecular Medicine’s Kimmel Center for Biology and Medicine at New York University, where she studied the molecular mechanisms of synaptic plasticity. Dr. Vivar’s international experience has enriched her research perspective and collaborations.

Research Interests

Dr. Vivar’s research interests encompass adult neurogenesis, synaptic plasticity, and the effects of physical exercise on brain function. She is particularly interested in how voluntary physical activity enhances hippocampal neurogenesis and improves cognitive functions such as learning and memory. Her studies aim to bridge the gap between animal models and human applications, providing insights into potential therapeutic strategies for neurodegenerative diseases and age-related cognitive decline. ​

Research Skills

Dr. Vivar possesses expertise in electrophysiology, neurophysiology, and cellular neuroscience. She is skilled in techniques such as in vivo and in vitro electrophysiological recordings, immunohistochemistry, and behavioral assessments related to learning and memory. Her proficiency in these methodologies enables her to investigate the intricate relationships between neuronal activity, synaptic plasticity, and behavior.

Awards and Honors

Throughout her career, Dr. Vivar has received recognition for her contributions to neuroscience. Her research has garnered significant citations, reflecting its impact on the scientific community. Additionally, she has been invited to speak at various international conferences and seminars, highlighting her expertise in the field. Her role as a guest speaker at events such as the Florida Atlantic Neuroscience Seminar Series underscores her standing in the scientific community. ​

Conclusion

Dr. Carmen Vivar’s dedication to understanding the mechanisms of neurogenesis and neuroplasticity has significantly advanced the field of neuroscience. Her research on the interplay between physical activity and brain function offers promising avenues for therapeutic interventions in neurodegenerative diseases and cognitive aging. Through her extensive experience and expertise, Dr. Vivar continues to contribute to the scientific community’s understanding of the brain’s capacity for adaptation and regeneration.

Publications Top Notes​

  1. Title: Running Reverses Chronic Stress‐Induced Changes in Serotonergic Modulation of Hippocampal Granule Cells and Altered Behavioural Responses
    Authors: Carmen Soto, Lazaro P. Orihuela, Grego Apostol, Carmen Vivar
    Year: 2025

  2. Title: Entorhinal cortex–hippocampal circuit connectivity in health and disease
    Authors: Melissa Hernández-Frausto, Carmen Vivar
    Year: 2024

  3. Title: Running throughout Middle-Age Keeps Old Adult-Born Neurons Wired
    Authors: Carmen Vivar, Benjamin D. Peterson, Alejandro Pinto, Emma Janke, Henriette van Praag
    Year: 2023

  4. Title: Rabies Virus Tracing of Monosynaptic Inputs to Adult-Born Granule Cells
    Author: Carmen Vivar
    Year: 2022

  5. Title: Long-term taurine administration improves motor skills in a tubulinopathy rat model by decreasing oxidative stress and promoting myelination
    Author: Carmen Vivar
    Year: 2021

  6. Title: Exercise and Hippocampal Memory Systems
    Authors: Voss, M.W.; Soto, C.; Yoo, S.; Sodoma, M.; Vivar, C.; van Praag, H.
    Year: 2019

  7. Title: Running changes the brain: The long and the short of it
    Authors: Vivar, C.; Van Praag, H.
    Year: 2017

  8. Title: Running reorganizes the circuitry of one-week-old adult-born hippocampal neurons
    Authors: Sah, N.; Peterson, B.D.; Lubejko, S.T.; Vivar, C.; Van Praag, H.
    Year: 2017

  9. Title: Adult hippocampal neurogenesis, aging and neurodegenerative diseases: Possible strategies to prevent cognitive impairment
    Author: Vivar, C.
    Year: 2015

  10. Title: Plant-derived flavanol (-)epicatechin mitigates anxiety in association with elevated hippocampal monoamine and BDNF levels, but does not influence pattern separation in mice
    Authors: Stringer, T.P.; Guerrieri, D.; Vivar, C.; Van Praag, H.
    Year: 2015

  11. Title: Running rewires the neuronal network of adult-born dentate granule cells
    Author: Carmen Vivar
    Year: 2015

 


Yashar Sarbaz | Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Yashar Sarbaz | Neuroscience | Best Researcher Award

Full-Time Faculty, ECE department at University of Tabriz, Iran

Dr. Yashar Sarbaz is a distinguished Iranian researcher specializing in biomedical engineering, with a focus on neurodegenerative disease modeling. Born on May 20, 1981, in Tabriz, Iran, he has consistently demonstrated academic excellence and a profound commitment to advancing medical science through interdisciplinary approaches. Dr. Sarbaz’s work integrates bioelectric engineering, control systems, and computational neuroscience, aiming to develop innovative solutions for complex neurological disorders. His extensive research has significantly contributed to the understanding and potential treatment of diseases such as Parkinson’s and Huntington’s.

Professional Profile

Education

Dr. Sarbaz’s academic journey commenced at the University of Tabriz, where he earned his Bachelor of Science in Electronic Engineering in 2002, graduating at the top of his class with a GPA of 17.44/20. He then pursued a Master of Science in Control Engineering at Sharif University of Technology, completing his degree in 2004 with a GPA of 18.19/20 and again ranking first in his class. His master’s thesis focused on modeling Parkinson’s disease and its treatment. In 2011, Dr. Sarbaz obtained his Ph.D. in Bioelectric Engineering from Amirkabir University of Technology. His doctoral research, titled “Modeling Parkinson Disease Using Chaotic Theory,” showcased his ability to apply complex mathematical frameworks to biomedical challenges, reflecting his interdisciplinary expertise.

Professional Experience

Dr. Sarbaz’s professional career began as a teaching assistant in the Department of Electrical Engineering at the University of Tabriz from 1998 to 2002. He continued in this role at Sharif University of Technology between 2002 and 2004, concurrently serving as a research assistant. From 2004 to 2006, he was a member of the academic staff at Sahand University of Technology. In 2005, he contributed as the Vice Scientific Committee Chair for the 12th Iranian Conference on Biomedical Engineering. Following his Ph.D., Dr. Sarbaz held teaching positions at Azad Islamic University and later returned to Sahand University. Since 2012, he has been a faculty member in the Department of Emerging Technologies at the University of Tabriz, where he continues to engage in teaching and research.

Research Interests

Dr. Sarbaz’s research interests are diverse and interdisciplinary, encompassing the modeling and simulation of biological systems, particularly neural diseases. He is proficient in system identification, the design of compensators and controllers, and the development of electronic circuits. His expertise extends to chaos theory, evolutionary and genetic algorithms, neural networks, and optimization techniques. Dr. Sarbaz is also deeply involved in electrophysiology and computational neuroscience, focusing on the design of rehabilitation systems. His work aims to bridge the gap between engineering and medicine, utilizing advanced computational methods to address complex biomedical challenges.

Research Skills

Dr. Sarbaz possesses a robust set of research skills that align with his interdisciplinary interests. He is adept at mathematical modeling and simulation of biological systems, employing system identification techniques to understand and predict system behaviors. His proficiency in designing electronic circuits and control systems is complemented by his application of chaos theory to model complex physiological phenomena. Dr. Sarbaz utilizes evolutionary and genetic algorithms for optimization problems and applies neural network methodologies to interpret complex data patterns. His skills in electrophysiology and computational neuroscience are instrumental in developing innovative rehabilitation systems and advancing the understanding of neural disorders.

Awards and Honors

Throughout his academic and professional career, Dr. Sarbaz has been recognized for his contributions to biomedical engineering and neuroscience. He consistently graduated at the top of his class during his academic pursuits, reflecting his dedication and excellence. His role as Vice Scientific Committee Chair at the 12th Iranian Conference on Biomedical Engineering in 2005 highlights his leadership within the scientific community. While specific awards and honors are not detailed in the provided information, Dr. Sarbaz’s extensive publication record and active participation in academic conferences underscore his respected status in his field.

Conclusion

Dr. Yashar Sarbaz exemplifies a commitment to advancing biomedical engineering through interdisciplinary research and education. His academic excellence, professional experience, and diverse research interests have positioned him as a leading figure in the modeling and treatment of neurodegenerative diseases. Dr. Sarbaz’s work not only contributes to the scientific understanding of complex neurological disorders but also holds promise for developing innovative therapeutic strategies. His dedication to integrating engineering principles with medical research continues to inspire and drive progress in the biomedical field.

Publication Top Notes

  1. A robust method for Parkinson’s disease diagnosis: Combining electroencephalography signal features with reconstructed phase space images

    • Author(s): Farnaz F. Garehdaghi, Yashar Y. Sarbaz
    • Year: 2025
  2. Cortical complexity alterations in motor subtypes of Parkinson’s disease: A surface-based morphometry analysis of fractal dimension

    • Author(s): Yousef Y. Dehghan, Yashar Y. Sarbaz
    • Year: 2024
  3. The influence of mental calculations on brain regions and heart rates

    • Author(s): Morteza M. Jafari Malali, Yashar Y. Sarbaz, Sepideh S. Zolfaghari, Armin A. Khodayarlou
    • Year: 2024
    • Citations: 1
  4. EEG-based classification of Alzheimer’s disease and frontotemporal dementia: a comprehensive analysis of discriminative features

    • Author(s): Mehran M. Rostamikia, Yashar Y. Sarbaz, Somayeh S. Makouei
    • Year: 2024
    • Citations: 2
  5. Extracting brain behavior change in patients with migraine by quantitative analysis of electroencephalogram signal of patients compared to healthy people

    • Author(s): Yashar Y. Sarbaz, Farnaz F. Garehdaghi, Saeed S. Meshgini
    • Year: 2024

 

Mariana Udo | Neuroscience | Best Researcher Award

Dr. Mariana Udo | Neuroscience | Best Researcher Award

Postdoctoral Fellow at University of Texas Health, United States

Dr. Mariana Sayuri Berto Udo is a dedicated researcher with extensive expertise in neurotoxicology, neurodegenerative diseases, cognition impairment, and aging. Currently a Postdoctoral Fellow at the Department of Neurology at Louisiana State University Health Sciences Center (LSU Health Shreveport), her work focuses on understanding vascular dementia and related pathways. Dr. Udo’s career spans multiple countries, including Brazil, Japan, and the United States, reflecting her global research perspective. She has secured prestigious funding from organizations such as the American Heart Association and has earned recognition for her scientific contributions. Dr. Udo has also served in academic mentorship, professional service, and research collaborations, making her a well-rounded scientist in her field.

Professional Profile

Education

Dr. Udo earned her Ph.D. (2013–2018) and MSc. (2010–2012) in Clinical and Toxicological Analysis from the University of São Paulo, Brazil, after completing her B.S. in Pharmaceutical Science at Methodist University of Piracicaba (2002–2006). She also obtained a certification in Clinical and Analytical Toxicology from the University of Campinas in 2007. Currently, she is a Postdoctoral Fellow at LSU Health Shreveport (2021–present), advancing her expertise in neurology. Her multidisciplinary education underlines her comprehensive understanding of pharmaceutical science, toxicology, and neurobiology.

Professional Experience

Dr. Udo has held various academic and research roles. As a Research Assistant at Asahikawa Medical University in Japan (2019–2021), she contributed to projects on neurophysiology and pharmacology. From 2013 to 2018, she was a lecturer at the Psychoanalytic Research Center, São Paulo, Brazil, where she taught neurophysiology and pharmacology. Additionally, she has contributed to scientific committees and evaluation boards, reflecting her dedication to advancing education and research.

Research Interests

Dr. Udo’s research interests encompass neurotoxicology, neurodegenerative diseases, cognition impairment, and aging. She is particularly focused on the organization and derangement of the microvasculature and the role of lipid rafts in neurodegenerative processes. Her work aims to elucidate mechanisms that contribute to vascular dementia, with an emphasis on improving understanding and treatment of age-related neurological disorders.

Research Skills

Dr. Udo is proficient in advanced research methodologies, including molecular and cellular biology, neurophysiological studies, and toxicological analysis. She has experience with preclinical models, pharmacological assessments, and data analysis related to neurodegeneration and cognition. Her ability to design and execute complex experiments, coupled with her analytical skills, has been instrumental in advancing her research objectives.

Awards and Honors

Dr. Udo has received numerous accolades for her work, including the Best Oral Presentation Award at the XXIV Benjamin Eurico Malucelli Scientific Meeting in 2015. She has also secured prestigious funding, such as the American Heart Association Postdoctoral Fellowship (2024–2025) and the Malcolm Feist Cardiovascular Research Fellowship (2023–2024). These recognitions reflect her significant contributions to the field of neurology and toxicology.

Conclusion

Dr. Mariana Sayuri Berto Udo is an excellent candidate for the Best Researcher Award due to her diverse academic background, international research experience, substantial funding achievements, and focus on impactful areas of neurology and toxicology. To further enhance her application, she could focus on increasing her publication record in high-impact journals and expanding global collaborations. Overall, her research and contributions make her a strong contender for this prestigious recognition.

Publication Top Notes

  1. Prenatal exposure to a low fipronil dose disturbs maternal behavior and reflex development in rats
    Authors: MSB Udo, TM Sandini, TM Reis, MM Bernardi, HS Spinosa
    Journal: Neurotoxicology and Teratology
    Year: 2014
    Citations: 51
  2. Desenvolvimento e estudos preliminares de estabilidade de formulações fotoprotetoras contendo Granlux GAI-45 TS
    Authors: M Chorilli, MS Udo, ME Cavallini, GR Leonardi
    Journal: Revista de Ciências Farmacêuticas Básica e Aplicada
    Year: 2006
    Citations: 36
  3. Prenatal exposure to integerrimine N-oxide impaired the maternal care and the physical and behavioral development of offspring rats
    Authors: TM Sandini, MSB Udo, TM Reis-Silva, MM Bernardi, HS Spinosa
    Journal: International Journal of Developmental Neuroscience
    Year: 2014
    Citations: 22
  4. Prenatal exposure to fipronil disturbs maternal aggressive behavior in rats
    Authors: JZ Magalhães, MSB Udo, AM Sánchez-Sarmiento, MPN Carvalho, …
    Journal: Neurotoxicology and Teratology
    Year: 2015
    Citations: 20
  5. M1 and M3 muscarinic receptors may play a role in the neurotoxicity of anhydroecgonine methyl ester, a cocaine pyrolysis product
    Authors: RCT Garcia, LMM Dati, LH Torres, MAA da Silva, MSB Udo, FMF Abdalla, …
    Journal: Scientific Reports
    Year: 2015
    Citations: 17
  6. Senecio brasiliensis e alcaloides pirrolizidínicos: toxicidade em animais e na saúde humana
    Authors: TM Sandini, MSB Udo, H de Souza Spinosa
    Journal: Biotemas
    Year: 2013
    Citations: 16
  7. Prenatal exposure to integerrimine N-oxide enriched butanolic residue from Senecio brasiliensis affects behavior and striatal neurotransmitter levels of rats in adulthood
    Authors: TM Sandini, MSB Udo, TM Reis-Silva, D Sanches, MM Bernardi, JC Flório, …
    Journal: International Journal of Developmental Neuroscience
    Year: 2015
    Citations: 13
  8. Fipronil: uses, pharmacological and toxicological features
    Authors: JZ Magalhães, TM Sandini, MSB Udo, A Fukushima, H de Souza-Spinosa
    Journal: Revinter
    Year: 2018
    Citations: 12
  9. Protein arginine methyltransferase 4 modulates nitric oxide synthase uncoupling and cerebral blood flow in Alzheimer’s disease
    Authors: GA Clemons, AC Silva, CH Acosta, MSB Udo, V Tesic, KM Rodgers, …
    Journal: Journal of Cellular Physiology
    Year: 2024
    Citations: 11
  10. Anhydroecgonine methyl ester, a cocaine pyrolysis product, contributes to cocaine-induced rat primary hippocampal neuronal death in a synergistic and time-dependent manner
    Authors: MSB Udo, MAA da Silva, S de Souza Prates, LF Dal’Jovem, …
    Journal: Archives of Toxicology
    Year: 2021
    Citations: 9